Table 2.

The effects on the level of serum S-100β and the percentage of cerebral infarct size ($\bar{X}\pm \text{s}$).

Group	N	Dose (mg/kg)	S-100β (ng/ml)	Percentage of cerebral infarct area (%)
Control group	16		15.147 ± 3.999**	0.0 ± 0.0**
Experiment group	9		22.636 ± 3.563	32.477 ± 7.044
Nimodipine group	10	30	16.751 ± 3.676**	17.912 ± 6.216**
High dose of verbenalin group	11	20	16.732 ± 4.007**	18.825 ± 9.213**
Medium dose of verbenalin group	11	10	17.188 ± 2.944**	22.417 ± 8.917**
Low dose of verbenalin group	10	5	17.860 ± 2.997**	27.507 ± 7.884

Note: Compared with the experiment group.

^*P < .05.

^**P < .01.